BRIEF — Hls Therapeutics Increases Normal Course Issuer Bid
Sept 24 (Reuters) — HLS Therapeutics Inc: Hls Therapeutics Increases Normal Course Issuer Bid Hls Therapeutics - Increases Normal Course Issuer Bid To 1,872,685 Common Shares Source text:... Further company coverage: HLS.TO (Reuters.Briefs@thomsonreuters.com;)